Skip to main content
Clinical Trials/NL-OMON37674
NL-OMON37674
Completed
Not Applicable

Clinical evaluation of the underlying mechanisms of targeted therapy related toxicities - mechanisms of toxicity of targeted agents

Vrije Universiteit Medisch Centrum0 sites120 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Skin and mucosal toxicities of targeted therapies
Sponsor
Vrije Universiteit Medisch Centrum
Enrollment
120
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients that will start palliative treatment with TKIs, mTOR inhibitors, ipilimumab, vemurafenib or anti\-EGFR antibodies and therefore fulfill according to their attending physician all the usual criteria for receiving standard targeted therapy as monotherapy.
  • 2\. PT\-INR/PTT \< 1\.5 x ULN.
  • 3\. Platelet count \> 100 x 109/l

Exclusion Criteria

  • \* Concomitant use of anticoagulants
  • \* Previous colonic surgery in the last 3 months
  • \* History of inflammatory bowel disease, or other active gastrointestinal infection

Outcomes

Primary Outcomes

Not specified

Similar Trials